Evaluating CD1a Immunohistochemistry for Tegumentary Leishmaniasis Diagnosis in the New World: A Focus on Colombia
Authors:
- Lucero Katherine Msc Aristizábal-ParraLALucero Katherine Msc Aristizábal-Parra
- Juan Pablo Ospina-GómezJOJuan Pablo Ospina-Gómez
- Lina Msc Restrepo-RiveraLRLina Msc Restrepo-Rivera
- Juan David RamírezJRJuan David Ramírez
- Carlos Mario Bsc Ospina-VarónCOCarlos Mario Bsc Ospina-Varón
- Héctor Msc Serrano-CollHSHéctor Msc Serrano-Coll
- 15 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 47 (3) , 197-205
Abstract
Introduction: Leishmaniasis, a chronic vector-borne disease caused by parasites of the genus Leishmania, presents diagnostic challenges. Conventional diagnostic methods struggle with accurate visualization of these parasites. Immunostaining with CD1a has demonstrated effectiveness in visualizing Leishmania parasites, particularly in the Old World. However, the application of CD1a immunostaining in Colombian leishmaniasis remains unexplored. Objective: To determine the utility of CD1a as an immunomarker in detecting chronic forms of tegumentary leishmaniasis. Materials and methods: This proof-of-concept study involved 48 paraffin-embedded samples categorized into 3 groups: moderate-to-high parasite load (n = 15), low load (n = 15), and chronic granulomatous inflammation (n = 13); 5 samples diagnosed with cutaneous histoplasmosis. These samples were stained with the immunomarker CD1a clone EP3622 for comparative analysis. In addition, CD1a immunohistochemistry was compared with 18S rDNA qPCR and hematoxylin–eosin staining to evaluate its performance in relation to these established methods. Results: CD1a immunohistochemistry was positive in 46.51% of the samples evaluated. This immunomarker showed lower sensitivity and negative predictive value than 18S rDNA qPCR and hematoxylin–eosin staining; specificity and negative predictive value were consistent. ROC indicated inferior discrimination for leishmaniasis compared with 18 s rDNA qPCR and hematoxylin–eosin staining. Conclusions: Immunohistochemistry for CD1a could be a diagnostic support in the detection of chronic forms of tegumentary leishmaniasis.Keywords
All Related Versions
This publication has 15 references indexed in Scilit:
- The role of CD1a expression in the diagnosis of cutaneous leishmaniasis, its relationship with leishmania species and clinicopathological featuresDermatologic Therapy, 2021
- The EP3662 clone of CD1a supports the diagnosis of New World cutaneous leishmaniasisJournal of Cutaneous Pathology, 2021
- The EP3622 clone of CD1a in the diagnosis of cutaneous leishmaniasisJournal of Cutaneous Pathology, 2020
- Real-time PCR to differentiate among Leishmania (Viannia) subgenus, Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis: Application on Brazilian clinical samplesActa Tropica, 2020
- Cutaneous leishmaniasis: A neglected disfiguring disease for womenInternational Journal of Women's Dermatology, 2019
- Histopathologic features of cutaneous leishmaniasis and use of CD1a staining for amastigotes in Old World and New World leishmaniasisJournal of Cutaneous Pathology, 2017
- Shape, form, function and Leishmania pathogenicity: from textbook descriptions to biological understandingOpen Biology, 2017
- Taxonomy, diversity, temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: A retrospective studyScientific Reports, 2016
- Morphological and immunohistochemical clues for the diagnosis of cutaneous leishmaniasis and the interpretation of CD1a statusJournal of the American Academy of Dermatology, 2016
- Transepidermal elimination in cutaneous leishmaniasis: a multiregional studyJournal of Cutaneous Pathology, 2012